| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.41B | $1.45B | $1.59B |
| YoY Revenue Growth % | -3.1% | -8.4% | — |
| Gross Profit | $202.4M | $219.5M | — |
| Gross Margin % | 14.4% | 15.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $28.8M | $54.5M | $61.2M |
| Operating Margin % | 2.0% | 3.8% | 3.9% |
| Net Income (GAAP) | $21.2M | $30.6M | $74.4M |
| EBITDA (Normalized) | $264.5M | $193.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $214.7M | $234.9M | $285.4M |
| Capital Expenditures (CapEx) | $294.6M | $173.2M | — |
| Free Cash Flow (FCF) | -$79.9M | $61.7M | $285.4M |
| FCF Margin % | -5.7% | 4.3% | 18.0% |
| Return on Invested Capital (ROIC %) | 2.1% | 5.0% | — |
| Cash & Short-Term Equivalents | $18.1M | $20.0M | — |
| Total Debt (Short + Long Term) | $285.0M | $85.0M | — |
| Total Stockholders' Equity | $805.6M | $793.5M | — |